Teva Pharmaceutical Industries reported slightly higher third-quarter profit, helped by sales of its Austedo treatment for Huntington’s Disease, and said production in Israel was unaffected by the country’s war with Hamas in Gaza.
The interest rate on the most common type of U.S. residential mortgage plunged last week by the most in nearly 16 months on the back of a rally in the Treasury market that drove down the benchmark yields used to set home loan costs.
Take-Two Interactive Software climbed 9% on Wednesday after a report the latest installment in its best-selling “Grand Theft Auto” videogame franchise could be announced as early as this week, likely ending fans’ years-long wait.
Warner Bros Discovery topped third-quarter profit estimates on Wednesday as the box-office hit “Barbie” helped offset a sluggish advertising market and a studios segment starved of content due to two Hollywood strikes.
Biogen on Wednesday cut its annual profit forecast, which slipped below Wall Street expectations, due to rising costs from the recent acquisition of Reata Pharmaceuticals and the launch of its Alzheimer’s treatment Leqembi.
Under Armour on Wednesday raised its annual gross margin expectations as the sportswear maker benefits from easing cost pressures and keeps a tight lid on expenses while struggling with tepid demand in its biggest market of North America.
Bayer’s finance chief said on Wednesday that the drugs and pesticides maker would remain very selective when considering any further settlements of U.S. litigation cases in which plaintiffs blame their cancer on Bayer’s Roundup weedkiller.
A handful of Canadian, German and Australian critical mineral explorers plan to command premium prices for key metals used in electric vehicles, promising quality and consistency in exchange for shifting reliance away from China, the dominant producer and price-setter.